Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized prediction and regulation of 5-FU exposure
2019-003740-77Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluorouracil in colorectal cancer (CRC) and pancreatic cancer (PC) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Achievement of optimal 5-FU exposure within two dose cycles. Started Dec 2019; status: completed.
02
Drugs
fluorouracil
03
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)
Beyond the preview
Go deeper on 2019-003740-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003740-77.